DIAGNOS Announces Grant of Stock Options

BROSSARD, Quebec, March 04, 2024 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces a grant of 250,000 stock options to one of its directors, Mr. Michael Braeuel, in connection with his appointment to the Corporation’s board of directors announced by way of news release on February 29, 2024.

Read More